OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis
Alessandra Pagano, Gilles Breuzard, Fabrice Parat, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5818-5818
Open Access | Times Cited: 19

Showing 19 citing articles:

Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 72

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing
Andrea Corsi, Cristina Bombieri, Maria Teresa Valenti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15383-15383
Open Access | Times Cited: 48

Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas
Allison R. Valerius, Mason Webb, Nouran Hammad, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 4, pp. 377-390
Closed Access | Times Cited: 6

TRx0237 induces apoptosis and enhances anti-PD-1 immunotherapeutic efficacy in anaplastic thyroid Cancer
Qingyang Ning, Jiaye Liu, Shijing Liu, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114610-114610
Closed Access

Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles
Shilah A. Bonnett, Alyssa B. Rosenbloom, Giang T. Ong, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 5, pp. 763-779
Open Access | Times Cited: 9

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells
Aurora Costa, Iris Maria Forte, Francesca Pentimalli, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3

Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
Rayane Hedna, Hervé Kovacic, Alessandra Pagano, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5386-5386
Open Access | Times Cited: 15

TRIP13 knockdown inhibits the proliferation, migration, invasion, and promotes apoptosis by suppressing PI3K/AKT signaling pathway in U2OS cells
Dechen Yu, Xiangyi Chen, Haiyu Zhou, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 4, pp. 3055-3064
Closed Access | Times Cited: 10

Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma
Jianhua Mu, Jianan Gong, Miao Shi, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Therapeutic Contribution of Tau-Binding Thiazoloflavonoid Hybrid Derivatives Against Glioblastoma Using Pharmacological Approach in 3D Spheroids
Emmanuelle T. Relave, Rayane Hedna, Attilio Di Maio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11785-11785
Open Access | Times Cited: 1

Molecular landscapes of glioblastoma cell lines revealed a group of patients that do not benefit from WWOX tumor suppressor expression
Żaneta Kałuzińska‐Kołat, Damian Kołat, Katarzyna Kośla, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 2

2-Aminothiazole-Flavonoid Hybrid Derivatives Binding to Tau Protein and Responsible for Antitumor Activity in Glioblastoma
Rayane Hedna, Attilio Di Maio, Maxime Robin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15050-15050
Open Access | Times Cited: 2

Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab
Christina Jensen, Simone Maarup, Hans Skovgaard Poulsen, et al.
Clinical & Translational Oncology (2024)
Closed Access

Page 1

Scroll to top